CurrentRheuma
Get Weekly

Topic · page 14 of 17

Osteoporosis & bone health

Postmenopausal, male and glucocorticoid-induced osteoporosis, fracture risk assessment and bone density, fragility fractures and their secondary prevention, anti-resorptive and anabolic drugs, treatment sequence and drug holidays

Briefs 521–560 of 659 placed here, newest publication first

Briefs in Osteoporosis & bone health

Newest publication first

  1. Osteoporos Int

    Effect of SGLT2 inhibitors on fractures, BMD, and bone metabolism markers in patients with type 2 diabetes mellitus: a systematic review and meta-analysis

    Meta-analysis

  2. Osteoporos Int

    External validation of a convolutional neural network algorithm for opportunistically detecting vertebral fractures in routine CT scans

    Diagnostic or prognostic study

  3. Osteoporos Int

    A study on whether deep learning models based on CT images for bone density classification and prediction can be used for opportunistic osteoporosis screening

    Diagnostic or prognostic study

  4. Osteoporos Int

    Estimating the economic burden of osteoporotic fractures in a multinational study: a real-world data perspective

    Cohort study

  5. Osteoporos Int

    Associations of dietary oxidative balance score with femur osteoporosis in postmenopausal women: data from the National Health and Nutrition Examination Survey

    Cross-sectional study

  6. Osteoporos Int

    Women’s perspectives regarding osteoporosis, fracture risk, and pharmacologic treatment: a cross-sectional study

    Cross-sectional study

  7. Clin Exp Rheumatol

    Long-term effectiveness and predictors of bisphosphonate treatment in type I complex regional pain syndrome

    Cohort study

  8. Osteoporos Int

    Costs of incident non-hip osteoporosis-related fractures in postmenopausal women from a payer perspective

    Cohort study

  9. Osteoporos Int

    Romosozumab is associated with greater trabecular bone score improvement compared to denosumab in postmenopausal osteoporosis

    Cohort study

  10. Osteoporos Int

    A real-world pharmacovigilance study of abaloparatide based on the FDA Adverse Event Reporting System (FAERS)

    Cohort study

  11. Osteoporos Int

    Does vertebral osteoporosis delay or accelerate lumbar disc degeneration? A systematic review

    Meta-analysis

  12. Osteoporos Int

    Previous fracture and subsequent fracture risk: a meta-analysis to update FRAX

    Meta-analysis

  13. Osteoporos Int

    Milk intake and hip fracture incidence in community-dwelling old Icelandic adults

    Cohort study

  14. Osteoporos Int

    Age- and dose-dependent effect of statin use on the risk of osteoporotic fracture in older adults

    Cohort study

  15. Osteoporos Int

    Clinical and biological parameters associated with fracture recurrence according to fracture liaison service dataset

    Cohort study

  16. JAMA Netw Open

    Adjusting FRAX Estimates of Fracture Probability Based on a Positive Vertebral Fracture Assessment

    Diagnostic or prognostic study

  17. Osteoporos Int

    A genome-wide genomic score added to standard recommended stratification tools does not improve the identification of patients with very low bone mineral density

    Diagnostic or prognostic study

  18. Osteoporos Int

    Comparison of anti-fracture effectiveness of zoledronate, ibandronate and alendronate versus denosumab in a registry-based cohort study

    Cohort study

  19. Osteoporos Int

    Drug adherence and treatment duration for denosumab and mortality risk among hip fracture patients

    Cohort study

  20. Arthritis Care Res (Hoboken)

    Clinical Features Associated With Rate of Fractures in Patients With Systemic Sclerosis: A US Cohort Study

    Cohort study

  21. Osteoporos Int

    Drug utilization analysis of osteoporosis medications in seven European electronic health databases

    Cohort study

  22. Arthritis Rheumatol

    Bone Loss in Inflammatory Rheumatic Musculoskeletal Disease Patients Treated With Low‐Dose Glucocorticoids and Prevention by Anti‐Osteoporosis Medications

    Cohort study

  23. Osteoporos Int

    Does adding exercise or physical activity to pharmacological osteoporosis therapy in patients with increased fracture risk improve bone mineral density and lower fracture risk? A systematic review and meta-analysis

    Meta-analysis

  24. Osteoporos Int

    Development, implementation and evaluation of a multinational FLS mentorship programme in Latin America

    Research article

  25. Osteoporos Int

    The Capture the Fracture® Partnership: an overview of a global initiative to increase the secondary fracture prevention care for patient benefit

    Research article

  26. J Rheumatol

    Validating the Fracture Risk Assessment Tool Score in a US Population-Based Study of Patients With Rheumatoid Arthritis

    Cohort study

  27. Osteoporos Int

    Update on the clinical use of trabecular bone score (TBS) in the management of osteoporosis: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), and the International Osteoporosis Foundation (IOF) under the auspices of WHO Collaborating Center for Epidemiology of Musculoskeletal Health and Aging

    Guideline or statement

  28. Osteoporos Int

    Liver enzyme inducing anticonvulsant drug use is associated with prevalent vertebral fracture

    Cross-sectional study

  29. Osteoporos Int

    Real-world evidence: new opportunities for osteoporosis research. Recommendations from a Working Group from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)

    Guideline or statement

  30. Osteoporos Int

    Establishing a Chinese older hip fracture registry for older patients: a Delphi study to define the focus and key variables for this registry

    Guideline or statement

  31. Osteoporos Int

    Impact of fragility fractures on activities of daily living and productivity in community-dwelling women: a multi-national study

    Cross-sectional study

  32. Osteoporos Int

    Risk comparison of osteonecrosis of the jaw in osteoporotic patients treated with bisphosphonates vs. denosumab: a multi-institutional retrospective cohort study in Taiwan

    Cohort study

  33. Osteoporos Int

    Causal relationship between type 2 diabetes mellitus and bone mineral density: a Mendelian randomization study in an East Asian population

    Research article

  34. Osteoporos Int

    Research priorities regarding the use of bisphosphonates for osteoporosis: a UK priority setting exercise

    Research article

  35. Osteoporos Int

    Urinary pentosidine level is associated with the risk of fracture in community-dwelling older adults: a prospective observational study

    Cohort study

  36. Osteoporos Int

    Osteoporosis medication adherence tools: a systematic review

    Meta-analysis

  37. Osteoporos Int

    Imaging of pelvic ring fractures in older adults and its clinical implications-a systematic review

    Meta-analysis

  38. Arthritis Res Ther

    Sex and age do not modify the association between glucocorticoids and bone mineral density in patients with rheumatoid arthritis: a cross-sectional study

    Cross-sectional study

  39. Joint Bone Spine

    Zoledronate and osteonecrosis of the jaw in osteoporosis: incidence and risk factors. Analysis of the French Pharmacovigilance Database

    Cohort study

  40. Osteoporos Int

    The impact of acute-phase reaction on mortality and re-fracture after zoledronic acid in hospitalized elderly osteoporotic fracture patients

    Cohort study

All 659 Briefs in ExploreShowing Briefs 521–560 of 659, newest first